Pharmaceutical Technology on MSN
CIPO grants patent to Palisade Bio’s PALI-2108
Patent number 3,174,137, which is titled Gut Microbiota Bioactivated PDE4 Inhibitor Precursors, encompasses the composition ...
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical ...
Tiny gold particles that act as carriers for lithium can be delivered directly to the brain in the form of a nasal spray.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback